With respect to assay development, quality assurance and, ultimately, clinical adoption, the primary subject of this review, these advantages are critical. Implicit with these advantages, TMAs enable ...
Organoids, as three-dimensional, self-organizing tissue models, have become indispensable tools in fields such as oncology, infectious disease, developmental biology, and regenerative medicine.
Researchers at Cincinnati Children's Hospital Medical Center in collaboration with Roche, have developed a next-generation human liver organoid microarray platform that could help predict which drugs ...
Enhancing Lateral Flow Device Design for Multiplexed Plasmonic Biosensing of Inflammatory Biomarkers
Abstract: This study investigates the enhancement of plasmonic nanoparticle-based multiplexed inflammatory biomarker detection sensitivity using a novel 3 × 3 microarray-based lateral flow device ...
BOSTON--(BUSINESS WIRE)--Sengenics Corporation LLC, a leader in immune response profiling to support scientific discovery and diagnostic development, today announced the launch of i-Ome Discovery, a ...
Phase II Trial of TAS-102 in Colorectal Cancer Patients With Circulating Tumor DNA-Defined Minimal Residual Disease After Adjuvant Therapy: INTERCEPT-TT A multiplex QIF assay was optimized on tissue ...
NEW YORK – After going private in 2022 and rebranding in 2023, AliveDx has shifted its focus from transfusion testing to clinical testing with plans to soon launch in the US and EU an expanding menu ...
NEW YORK – Swiss firm AliveDx said Thursday that it has submitted for US Food and Drug Administration 510(k) marketing clearance a multiplex immunoassay that is used to aid the diagnosis of systemic ...
Planar waveguide (PWG) technology (right) has the advantage over conventional epifluorescence excitation (left) for surface-confined assays in that only surface-bound fluorphores respond to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results